Johnson & Johnson (JNJ)
259.24
+2.26
(+0.88%)
USD |
NYSE |
Aug 07, 16:00
259.60
+0.36
(+0.14%)
After-Hours: 19:59
Johnson & Johnson Debt to Equity Ratio : 0.5771 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.5771 |
| March 31, 2026 | 0.6773 |
| December 31, 2025 | 0.605 |
| September 30, 2025 | 0.5777 |
| June 30, 2025 | 0.6469 |
| March 31, 2025 | 0.669 |
| December 31, 2024 | 0.5292 |
| September 30, 2024 | 0.5096 |
| June 30, 2024 | 0.58 |
| March 31, 2024 | 0.4803 |
| December 31, 2023 | 0.4425 |
| September 30, 2023 | 0.4201 |
| June 30, 2023 | 0.6068 |
| March 31, 2023 | 0.7465 |
| December 31, 2022 | 0.5305 |
| September 30, 2022 | 0.4293 |
| June 30, 2022 | 0.4269 |
| March 31, 2022 | 0.4437 |
| December 31, 2021 | 0.4695 |
| September 30, 2021 | 0.4828 |
| June 30, 2021 | 0.4812 |
| March 31, 2021 | 0.5106 |
| December 31, 2020 | 0.5747 |
| September 30, 2020 | 0.5856 |
| June 30, 2020 | 0.4826 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.45 |
| December 31, 2019 | 0.4823 |
| September 30, 2019 | 0.519 |
| June 30, 2019 | 0.5006 |
| March 31, 2019 | 0.5135 |
| December 31, 2018 | 0.5101 |
| September 30, 2018 | 0.4836 |
| June 30, 2018 | 0.5102 |
| March 31, 2018 | 0.5143 |
| December 31, 2017 | 0.5748 |
| September 30, 2017 | 0.4754 |
| June 30, 2017 | 0.4807 |
| March 31, 2017 | 0.4602 |
| December 31, 2016 | 0.3852 |
| September 30, 2016 | 0.3709 |
| June 30, 2016 | 0.3621 |
| March 31, 2016 | 0.3214 |
| December 31, 2015 | 0.2791 |
| September 30, 2015 | 0.276 |
| June 30, 2015 | 0.2714 |
| March 31, 2015 | 0.2797 |
| December 31, 2014 | 0.269 |
| September 30, 2014 | 0.1993 |
| June 30, 2014 | 0.2194 |
| March 31, 2014 | 0.2258 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Eli Lilly & Co. | 1.621 |
| Merck & Co., Inc. | 1.071 |
| Pfizer Inc. | -- |
| Bristol Myers Squibb Co. | 2.019 |
| Liquidia Corp. | 1.702 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 201.06B |
| Total Liabilities (Quarterly) | 116.09B |
| Shareholders Equity (Quarterly) | 84.97B |
| Current Ratio | 1.089 |
| Net Debt Paydown Yield | 0.11% |